AMRX logo

Amneal Pharmaceuticals (AMRX) Short Term Debt

Annual Short Term Debt

$227.62 M
+$122.98 M+117.53%

December 31, 2023


Summary


Performance

AMRX Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAMRXbalance sheetmetrics:

Quarterly Short Term Debt

$381.02 M
-$70.63 M-15.64%

September 30, 2024


Summary


Performance

AMRX Quarterly Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAMRXbalance sheetmetrics:

Short Term Debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

AMRX Short Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+117.5%+211.0%
3 y3 years+296.1%+128.9%
5 y5 years+948.2%+128.9%

AMRX Short Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+394.4%-15.6%+727.6%
5 y5-yearat high+516.0%-15.6%+931.1%
alltimeall timeat high+948.2%-15.6%+1654.6%

Amneal Pharmaceuticals Short Term Debt History

DateAnnualQuarterly
Sep 2024
-
$381.02 M(-15.6%)
Jun 2024
-
$451.65 M(+97.5%)
Mar 2024
-
$228.66 M(+0.5%)
Dec 2023
$227.62 M(+117.5%)
$227.62 M(+85.8%)
Sep 2023
-
$122.51 M(-26.4%)
Jun 2023
-
$166.48 M(+14.6%)
Mar 2023
-
$145.22 M(+38.8%)
Dec 2022
$104.64 M(+127.3%)
$104.64 M(-1.8%)
Sep 2022
-
$106.57 M(-18.7%)
Jun 2022
-
$131.13 M(+182.9%)
Mar 2022
-
$46.35 M(+0.7%)
Dec 2021
$46.04 M
$46.04 M(+1.3%)
Sep 2021
-
$45.45 M(+4.0%)
DateAnnualQuarterly
Jun 2021
-
$43.70 M(+3.2%)
Mar 2021
-
$42.36 M(-26.3%)
Dec 2020
$57.47 M(+55.5%)
$57.47 M(+24.4%)
Sep 2020
-
$46.20 M(-1.9%)
Jun 2020
-
$47.08 M(-86.4%)
Mar 2020
-
$346.94 M(+838.9%)
Dec 2019
$36.95 M(+70.2%)
$36.95 M(-3.5%)
Sep 2019
-
$38.29 M(+0.6%)
Jun 2019
-
$38.05 M(+0.5%)
Mar 2019
-
$37.85 M(+74.3%)
Dec 2018
$21.71 M(-75.7%)
$21.71 M(-89.1%)
Sep 2018
-
$199.82 M(+101.4%)
Jun 2018
-
$99.23 M(+10.9%)
Dec 2017
$89.48 M
$89.48 M

FAQ

  • What is Amneal Pharmaceuticals annual short term debt?
  • What is the all time high annual short term debt for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals annual short term debt year-on-year change?
  • What is Amneal Pharmaceuticals quarterly short term debt?
  • What is the all time high quarterly short term debt for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals quarterly short term debt year-on-year change?

What is Amneal Pharmaceuticals annual short term debt?

The current annual short term debt of AMRX is $227.62 M

What is the all time high annual short term debt for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high annual short term debt is $227.62 M

What is Amneal Pharmaceuticals annual short term debt year-on-year change?

Over the past year, AMRX annual short term debt has changed by +$122.98 M (+117.53%)

What is Amneal Pharmaceuticals quarterly short term debt?

The current quarterly short term debt of AMRX is $381.02 M

What is the all time high quarterly short term debt for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high quarterly short term debt is $451.65 M

What is Amneal Pharmaceuticals quarterly short term debt year-on-year change?

Over the past year, AMRX quarterly short term debt has changed by +$258.51 M (+211.01%)